Mutation affecting the pnt-P1 isoform. Indel in the P1-specific exon 1, resulting in a frameshift and premature stop codon that deletes the 445 C-terminal amino acids (including the Ets DNA-binding domain).
Appears to be a deletion of 13 bp and insertion of 8 (CTGCGACT) after amino acid 176 causing a net deletion of 5 bp. Leads to a frameshift and early translation termination.
CTGCGACT
pntP1-90 has decreased cell number | larval stage phenotype, enhanceable by btd[+]/btdXG
pntP1-90 has abnormal neuroanatomy | larval stage phenotype, enhanceable by btd[+]/btdXG
pntP1-90 has decreased cell number | larval stage phenotype, enhanceable by btd[+]/btdMD808
pntP1-90 has abnormal neuroanatomy | larval stage phenotype, enhanceable by btd[+]/btdMD808
pntP1-90 has increased cell number | larval stage phenotype, enhanceable by Df(2L)erm2/+
pntP1-90 has abnormal neuroanatomy | larval stage phenotype, enhanceable by Df(2L)erm2/+
pntP1-90 has increased cell number | larval stage phenotype, suppressible by btd[+]/btdXG
pntP1-90 has increased cell number | larval stage phenotype, suppressible by btd[+]/btdMD808
pntP1-90 has increased cell number | larval stage phenotype, suppressible by Scer\GAL4GMR9D11/ermUAS.Tag:HA
pntP1-90 has abnormal neuroanatomy | larval stage phenotype, suppressible by Scer\GAL4GMR9D11/ermUAS.Tag:HA
pntP1-90 has intermediate neuronal progenitor | larval stage phenotype, enhanceable by btd[+]/btdXG
pntP1-90 has intermediate neuronal progenitor | larval stage phenotype, enhanceable by btd[+]/btdMD808
pntP1-90 has type II neuroblast | larval stage phenotype, enhanceable by Df(2L)erm2/+
pntP1-90 has type II neuroblast | larval stage phenotype, suppressible | partially by btd[+]/btdXG
pntP1-90 has type II neuroblast | larval stage phenotype, suppressible | partially by btd[+]/btdMD808
pntP1-90 has type II neuroblast | larval stage phenotype, suppressible by Scer\GAL4GMR9D11/ermUAS.Tag:HA
btdXG/+ or btdMD808/+ enhances the loss of intermediate neural progenitors, but suppresses the increased number of Asense-negative type II neuroblasts, although (in the case of btdMD808/+) does not suppress the increased number of total neuroblasts seen in pntP1-90/pntP1-90 mutant larvae.
Df(2L)erm2/+ significantly enhances the increase in type II neuroblasts seen in pntP1-90/pntP1-90 mutant larvae.
Expression of ermScer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR9D11 significantly suppresses the increase in type II neuroblasts seen in pntP1-90/pntP1-90 mutant larvae.